@gudenyuden そこまでのデータがあるのかなと検索してみたら、わりと最近のでそんなのありました。 https://t.co/MVsSclXlTL
@BenjaminBesseMD .@BenjaminBesseMD How does that square with this recent study suggesting cytotoxic chemotherapy works better in the afternoon? Would that mean people should get different treatments at different times of the day? https://t.co/8khxrA418D
原文読むと朝8:30からR-CHOP開始してて、患者は7時過ぎには病院来てるのかとかスタッフの勤務時間とかが気になって内容が入ってこない…
m◯のメーリングリストで「DLBCL女性患者は午後のR-CHOP療法で予後改善」っていうのがあって、マジかよ!?と思って原文見たら、めっちゃ交絡ありそうなヤツだった。 https://t.co/G9OMXzmUvJ
JCI Insight - Chemotherapy delivery time affects treatment outcomes of female patients with diffuse large B cell lymphoma https://t.co/qGx6uUFah2 DLBCL女性患者は午後のR-CHOP療法で予後改善 女性は循環白血球および好中球の日内変動が大きいことでこの性差が説明できるとされた 日内変動
Afternoon chemotherapy increases survival rate by 2-fold and progression-free survival by 4-fold compared to morning. It may be due to the strong circadian rhythms in white blood cell (WBC) count in females. #Chronotherapy https://t.co/Pacd62iZkz @SatchinP
RT @medical_xpress: Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study @JCI_Insight…
Giving chemotherapy in the afternoon rather than in the morning improves survival in women - but not men - with certain lymphomas. https://t.co/1X4fMPfAx8
#ClinicalMedicine: Morning delivery of chemotherapy worsens outcomes in female DLBCL patients: https://t.co/XOAu7he9qj @umichkim #Hematology #Oncology https://t.co/B6iyurwSNS
RT @medical_xpress: Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study @JCI_Insight…
RT @umichkim: News about our recent research about #chronotherapy Treatment timing indeed matters for cancer treatment outcomes more than 1…
RT @medical_xpress: Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study @JCI_Insight…
News about our recent research about #chronotherapy Treatment timing indeed matters for cancer treatment outcomes more than 10-fold. #Circadian @SRBR_Outreach
RT @drkpavithran: R-CHOP chemo in the afternoon reduces toxicity and improves efficacy and the survival outcome in female DLBCL patients ht…
RT @drkpavithran: R-CHOP chemo in the afternoon reduces toxicity and improves efficacy and the survival outcome in female DLBCL patients ht…
RT @medical_xpress: Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study @JCI_Insight…
RT @medical_xpress: Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study @JCI_Insight…
Chemotherapy delivery time affects treatment outcomes of female patients with diffuse large B cell lymphoma 👇 https://t.co/Zvb5ZQ1XGH https://t.co/gIiUZ5UF0A
RT @drkpavithran: R-CHOP chemo in the afternoon reduces toxicity and improves efficacy and the survival outcome in female DLBCL patients ht…
RT @medical_xpress: Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study @JCI_Insight…
RT @medical_xpress: Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study @JCI_Insight…
R-CHOP chemo in the afternoon reduces toxicity and improves efficacy and the survival outcome in female DLBCL patients https://t.co/eetXetPnx4 https://t.co/lMtUnpXl0Q
RT @medical_xpress: Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study @JCI_Insight…
RT @medical_xpress: Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study @JCI_Insight…
RT @medical_xpress: Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study @JCI_Insight…
RT @medical_xpress: Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study @JCI_Insight…
Chemotherapy in the afternoon dramatically improves treatment outcomes in female lymphoma patients: Study @JCI_Insight https://t.co/YdbN6OhhiI https://t.co/VHl1Jp57u5
RT @umichkim: We found that afternoon chemotherapy increases survival rate by 2-fold and progression-free survival by 4-fold compared to mo…
RT @umichkim: We found that afternoon chemotherapy increases survival rate by 2-fold and progression-free survival by 4-fold compared to mo…
RT @umichkim: We found that afternoon chemotherapy increases survival rate by 2-fold and progression-free survival by 4-fold compared to mo…
RT @umichkim: We found that afternoon chemotherapy increases survival rate by 2-fold and progression-free survival by 4-fold compared to mo…
RT @umichkim: We found that afternoon chemotherapy increases survival rate by 2-fold and progression-free survival by 4-fold compared to mo…
RT @umichkim: We found that afternoon chemotherapy increases survival rate by 2-fold and progression-free survival by 4-fold compared to mo…
It is incredible, how much it matters!
RT @ls_siam: Circadian rhythms are everywhere. The time of day for receiving treatment affects the survival rate of chemotherapy.
Circadian rhythms are everywhere. The time of day for receiving treatment affects the survival rate of chemotherapy.
RT @umichkim: We found that afternoon chemotherapy increases survival rate by 2-fold and progression-free survival by 4-fold compared to mo…
RT @umichkim: We found that afternoon chemotherapy increases survival rate by 2-fold and progression-free survival by 4-fold compared to mo…
RT @umichkim: We found that afternoon chemotherapy increases survival rate by 2-fold and progression-free survival by 4-fold compared to mo…
We found that afternoon chemotherapy increases survival rate by 2-fold and progression-free survival by 4-fold compared to morning one due to the strong #circadian rhythms in white blood cell (WBC) count in females. #Chronotherapy #Rchop #Cancer https://t